IL-6 antagonists and uses thereof
US11459386B2 · kind B2 · utility
0Cited by
36References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 26, 2018 |
| Grant date | Oct 4, 2022 |
| Priority date | — |
| Expiry date | Sep 28, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Interleukin-6 (IL-6) antagonists are provided that are specific for binding to site II of IL-6. Methods of using such inhibitors to treat IL-6 related diseases, e.g., disease of the eye such as diabetic macular edema are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.